SCHEMBL2495323

SCHEMBL2495323

CCCNc1ccccc1[CH]c1ccccc1NCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
MAPT P10636 2/20 0.43
HTT P42858 1/20 0.43
PDE5A O76074 2/20 0.37
KDM4E B2RXH2 3/20 0.36
GLA P06280 1/20 0.36
SLC2A1 P11166 1/20 0.35
MAPK1 P28482 1/20 0.34
APP P05067 1/20 0.34
KDM6B O15054 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
EPHX1 P07099 1/20 0.33
TLR8 Q9NR97 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492316 0.88 TLR8 (0.45) MAPTHTTKDM4EKDM6BKDM4C
SCHEMBL5546038 0.84 MEN1 (0.44) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL10628437 0.84 IDO1 (0.43) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL10313820 0.82 IDO1 (0.42) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL11512622 0.82 IDO1 (0.55) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL3667559 0.80 IDO1 (0.40) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL1485722 0.74 MAPT (0.78) IDO1MAPTHTTSLC2A1ALDH1A1
SCHEMBL13477752 0.74 IDO1 (0.48) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL12984545 0.73 SMN1; SMN2 (0.49) IDO1MAPTHTTPDE5AKDM4E
SCHEMBL17921774 0.73 L3MBTL1 (0.52) IDO1MAPTHTTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH IDO1 275/4885MAPT 3454/4885HTT 1217/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 IDO1 267/4885MAPT 3294/4885HTT 946/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R IDO1 320/4885MAPT 3128/4885HTT 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.